Cder-2023-118902 ocpdars purchase of molecular biology reagents.

Ended Awarded Last action

Contract number
75F40123F19004
Awardee
Awarding agency
Obligated
$33,855

Award facts

Contract value 100% obligated
$33,854.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Germantown, MD, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Deobligation/closeout -$416
Original award $34,271

About this award

The Food and Drug Administration issued a delivery order to Qiagen, LLC on September 9, 2023, with a ceiling value of $33,854.88 for the purchase of molecular biology reagents under the FDA's Indefinite Delivery/Indefinite Quantity contract for molecular biology reagents supporting regulatory testing and evaluation activities.

Place of performance is Germantown, MD. The order was completed and closed out on September 10, 2024. Pricing is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract 75F40123F19004?

75F40123F19004 was awarded to Qiagen, LLC by Food and Drug Administration (Department of Health and Human Services) on September 9, 2023.

How much is contract 75F40123F19004 worth?

The government has obligated $33,855 on 75F40123F19004.

Is contract 75F40123F19004 an order under another contract?

Yes. 75F40123F19004 is a delivery order under 75F40121D00009, an indefinite delivery contract.

Was contract 75F40123F19004 competed?

The extent of competition for 75F40123F19004 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award